683 Capital Management, LLC Bridge Bio Pharma, Inc. Transaction History
683 Capital Management, LLC
- $1.4 Billion
- Q4 2024
A detailed history of 683 Capital Management, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, 683 Capital Management, LLC holds 635,000 shares of BBIO stock, worth $23.4 Million. This represents 1.25% of its overall portfolio holdings.
Number of Shares
635,000
Previous 550,000
15.45%
Holding current value
$23.4 Million
Previous $14 Million
24.43%
% of portfolio
1.25%
Previous 1.27%
Shares
4 transactions
Others Institutions Holding BBIO
# of Institutions
321Shares Held
176MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$931 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$926 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$556 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$459 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$228 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.46B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...